Literature DB >> 17204684

Glycated hemoglobin and risk of stroke in people without known diabetes in the European Prospective Investigation into Cancer (EPIC)-Norfolk prospective population study: a threshold relationship?

Phyo K Myint1, Shubhada Sinha, Nicholas J Wareham, Sheila A Bingham, Robert N Luben, Ailsa A Welch, Kay-Tee Khaw.   

Abstract

BACKGROUND AND
PURPOSE: Diabetes is a well-recognized risk factor for cardiovascular diseases. Evidence suggests a linear relationship between blood glucose and myocardial infarction, even at blood glucose concentrations below the threshold for diabetes. The relationship between blood glucose concentration and stroke in people without established diabetes has been studied less extensively.
METHODS: We examined the prospective relationship between usual blood glucose level measured by glycohemoglobin (HbA(1c)) concentrations and incident stroke risk in a general population without diabetes and stroke at baseline assessment in the European Prospective Investigation Into Cancer (EPIC)-Norfolk.
RESULTS: A total of 10,489 men and women aged 40 to 79 years at baseline were followed up (mean=8.5 years). Mean age, systolic and diastolic blood pressure, body mass index, total cholesterol, triglycerides, and proportion of current smokers increased and mean high-density lipoprotein cholesterol decreased with increasing HbA(1c) concentrations. There were 164 incident strokes identified over 88 652 person-years. After adjustment for age, sex, and cardiovascular risk factors, the relative risks (95% CI) for stroke for participants with HbA(1c) concentrations 5% to 5.4%, 5.5% to 6.9%, and > or =7% were 0.78 (0.50 to 1.22), 0.83 (0.54 to 1.27), and 2.83 (1.40 to 5.74), respectively, compared with those with HbA(1c) <5%.
CONCLUSIONS: In contrast to the continuous linear relationship observed between blood glucose level and coronary heart disease risk, the association between blood glucose level and stroke risk appears to be more consistent with a threshold relationship. These observations may give insights into the differing pathogenesis of different vascular diseases.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17204684     DOI: 10.1161/01.STR.0000254549.75763.5f

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  20 in total

Review 1.  Diabetes mellitus and Alzheimer's disease: shared pathology and treatment?

Authors:  Kawser Akter; Emily A Lanza; Stephen A Martin; Natalie Myronyuk; Melanie Rua; Robert B Raffa
Journal:  Br J Clin Pharmacol       Date:  2011-03       Impact factor: 4.335

2.  Insulin, glucose and glycated hemoglobin in Alzheimer's and vascular dementia with and without superimposed Type II diabetes mellitus condition.

Authors:  R O Domínguez; E R Marschoff; E M Guareschi; M G Repetto; A L Famulari; M A Pagano; J A Serra
Journal:  J Neural Transm (Vienna)       Date:  2007-08-30       Impact factor: 3.575

3.  Diagnosing diabetes--time for a change?

Authors:  K Borch-Johnsen; S Colagiuri
Journal:  Diabetologia       Date:  2009-09-08       Impact factor: 10.122

4.  Haemoglobin A1c levels and subsequent cardiovascular disease in persons without diabetes: a meta-analysis of prospective cohorts.

Authors:  R Santos-Oliveira; C Purdy; M Pereira da Silva; A M dos Anjos Carneiro-Leão; M Machado; T R Einarson
Journal:  Diabetologia       Date:  2011-02-22       Impact factor: 10.122

5.  Cortical neurons develop insulin resistance and blunted Akt signaling: a potential mechanism contributing to enhanced ischemic injury in diabetes.

Authors:  Bhumsoo Kim; Kelli A Sullivan; Carey Backus; Eva L Feldman
Journal:  Antioxid Redox Signal       Date:  2011-03-08       Impact factor: 8.401

Review 6.  Reducing the risk of stroke in type 2 diabetes: pathophysiological and therapeutic perspectives.

Authors:  Dirk Sander; Mark T Kearney
Journal:  J Neurol       Date:  2009-04-29       Impact factor: 4.849

7.  Optimum control of blood glucose for prevention and treatment of ischemic and hemorrhagic stroke.

Authors:  Veronique Guyomard; Phyo Kyaw Myint
Journal:  Curr Treat Options Cardiovasc Med       Date:  2009-06

Review 8.  Shifting the disease management paradigm from glucose: what are the cons?

Authors:  Markolf Hanefeld; Stefan R Bornstein; Frank Pistrosch
Journal:  Diabetes Care       Date:  2009-11       Impact factor: 19.112

9.  Relationship Between Glycated Haemoglobin and Carotid Atherosclerotic Disease Among Patients with Acute Ischaemic Stroke.

Authors:  Saima Nazish; Azra Zafar; Rizwana Shahid; Aishah Albakr; Fahd A Alkhamis; Danah Aljaafari; Majed Alabdali; Abdullah Alsulaiman; Faisal A Al-Mulla
Journal:  Sultan Qaboos Univ Med J       Date:  2018-12-19

10.  Assessing the linear and non-linear association of HbA1c with cardiovascular disease: a Mendelian randomisation study.

Authors:  Shan Luo; Shiu Lun Au Yeung; C Mary Schooling
Journal:  Diabetologia       Date:  2021-08-03       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.